Archean Chemical Industries Limited (BOM:543657)
569.15
-11.35 (-1.96%)
At close: Feb 13, 2026
BOM:543657 Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Revenue | 11,257 | 10,410 | 13,301 | 14,411 | 11,304 | 7,408 |
Revenue Growth (YoY) | 14.94% | -21.73% | -7.70% | 27.48% | 52.60% | 21.80% |
Cost of Revenue | 543.33 | 91.96 | 1,124 | 192.41 | 537.06 | 212.55 |
Gross Profit | 10,714 | 10,318 | 12,177 | 14,218 | 10,767 | 7,195 |
Selling, General & Admin | 861.19 | 746.95 | 836 | 795.61 | 462.37 | 440.49 |
Other Operating Expenses | 7,011 | 6,422 | 6,699 | 7,083 | 5,596 | 4,128 |
Operating Expenses | 8,785 | 7,963 | 8,239 | 8,565 | 6,727 | 5,122 |
Operating Income | 1,929 | 2,355 | 3,938 | 5,654 | 4,040 | 2,073 |
Interest Expense | -141.77 | -66.73 | -69.21 | -940.09 | -1,609 | -1,303 |
Interest & Investment Income | 31.13 | 31.13 | 21.21 | 41.36 | 13.62 | 8.57 |
Currency Exchange Gain (Loss) | 104.44 | 104.44 | 79.05 | 127.76 | 23.9 | 92.85 |
Other Non Operating Income (Expenses) | -89.34 | -10.18 | 41.51 | 38.84 | 28.76 | 21.29 |
EBT Excluding Unusual Items | 1,833 | 2,414 | 4,011 | 4,922 | 2,497 | 893.22 |
Gain (Loss) on Sale of Investments | 228.63 | 228.63 | 231.02 | 37.8 | 12.59 | 13.98 |
Gain (Loss) on Sale of Assets | -4.24 | -4.24 | -0.36 | 0.55 | 0.21 | - |
Asset Writedown | - | - | - | - | - | -2.55 |
Other Unusual Items | - | -401.83 | - | - | - | - |
Pretax Income | 2,059 | 2,238 | 4,272 | 5,117 | 2,510 | 904.65 |
Income Tax Expense | 589.88 | 616.22 | 1,082 | 1,291 | 628.04 | 238.59 |
Earnings From Continuing Operations | 1,469 | 1,621 | 3,190 | 3,826 | 1,882 | 666.06 |
Minority Interest in Earnings | -4.67 | 0.04 | 0.07 | - | - | - |
Net Income | 1,465 | 1,621 | 3,190 | 3,826 | 1,882 | 666.06 |
Net Income to Common | 1,465 | 1,621 | 3,190 | 3,826 | 1,882 | 666.06 |
Net Income Growth | -11.88% | -49.17% | -16.62% | 103.26% | 182.57% | - |
Shares Outstanding (Basic) | 123 | 123 | 123 | 110 | 103 | 103 |
Shares Outstanding (Diluted) | 123 | 124 | 123 | 111 | 103 | 103 |
Shares Change (YoY) | -0.13% | 0.17% | 11.47% | 7.10% | - | - |
EPS (Basic) | 11.88 | 13.14 | 25.90 | 34.66 | 18.22 | 6.45 |
EPS (Diluted) | 11.86 | 13.12 | 25.87 | 34.59 | 18.22 | 6.45 |
EPS Growth | -11.83% | -49.29% | -25.21% | 89.85% | 182.50% | - |
Free Cash Flow | - | -873.38 | 1,715 | 3,962 | 2,179 | 1,086 |
Free Cash Flow Per Share | - | -7.07 | 13.91 | 35.82 | 21.10 | 10.51 |
Dividend Per Share | - | 3.000 | 3.000 | 2.500 | - | - |
Dividend Growth | - | - | 20.00% | - | - | - |
Gross Margin | 95.17% | 99.12% | 91.55% | 98.67% | 95.25% | 97.13% |
Operating Margin | 17.13% | 22.62% | 29.61% | 39.23% | 35.74% | 27.98% |
Profit Margin | 13.01% | 15.58% | 23.98% | 26.55% | 16.65% | 8.99% |
Free Cash Flow Margin | - | -8.39% | 12.89% | 27.50% | 19.28% | 14.65% |
EBITDA | 2,695 | 3,066 | 4,577 | 6,258 | 4,639 | 2,565 |
EBITDA Margin | 23.94% | 29.45% | 34.41% | 43.43% | 41.04% | 34.62% |
D&A For EBITDA | 765.85 | 711.16 | 638.25 | 604.12 | 599.51 | 491.81 |
EBIT | 1,929 | 2,355 | 3,938 | 5,654 | 4,040 | 2,073 |
EBIT Margin | 17.13% | 22.62% | 29.61% | 39.23% | 35.74% | 27.98% |
Effective Tax Rate | 28.65% | 27.54% | 25.33% | 25.23% | 25.02% | 26.37% |
Revenue as Reported | 11,551 | 10,783 | 13,734 | 14,843 | 11,428 | 7,548 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.